A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux
P. V. Jena, D. Roxbury, T. V. Galassi, L. Akkari, C. P. Horoszko, D. B. Iaea, J. Budhathoki-Uprety, N. H. Pipalia, A. S. Haka, J. D. Harvey, J. Mittal, F. R. Maxfield, J. A. Joyce, D. A. Heller
Abstract
Lipid accumulation within the lumen of endolysosomal vesicles is observed in various pathologies including atherosclerosis, liver disease, neurological disorders, lysosomal storage disorders, and cancer. Current methods cannot measure lipid flux specifically within the lysosomal lumen of live cells. We developed an optical reporter, composed of a photoluminescent carbon nanotube of a single chirality, which responds to lipid accumulation via modulation of the nanotubes optical bandgap. The engineered nanomaterial, composed of short-single stranded DNA and a single nanotube chirality, localizes exclusively to the lumen of endolysosomal organelles without adversely affecting cell viability or proliferation, or organelle morphology, integrity, or function. The emission wavelength of the reporter can be spatially resolved from within the endolysosomal lumen to generate quantitative maps of lipid content in live cells. Endolysosomal lipid accumulation in cell lines, an example of drug-induced phospholipidosis (DIPL), was observed for multiple drugs in macrophages, and measurements of patient-derived Niemann-Pick type C fibroblasts identified lipid accumulation and phenotypic reversal of this lysosomal storage disease. Single-cell measurements using the reporter discerned sub-cellular differences in equilibrium lipid content, illuminating significant intracellular heterogeneity among endolysosomal organelles of differentiating bone marrow-derived monocytes. Single-cell kinetics of lipoprotein-derived cholesterol accumulation within macrophages revealed rates that differed among cells by an order of magnitude. This carbon nanotube optical reporter of endolysosomal lipid content in live cells confers new capabilities for drug development processes and the investigation of lipid-linked diseases.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe
Daniel J. Rohrbach, Kevin A. Carter, … Ulaş Sunar·International Journal of Molecular SciencesPeer-reviewed·Jan 30, 2025
- Long-Term In Vivo Biocompatibility of Single-Walled Carbon Nanotubes
T. V. Galassi, M. Antman-Passig, … D. A. Heller·bioRxiv·Dec 9, 2019
- Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
M. Herrera, J. Kim, … G. Sahay·bioRxiv·Dec 2, 2020
- Lysosome-targeted lipid probes reveal sterol transporters NPC1 and LIMP2 as sphingosine transporters
J. Altuzar, J. Notbohm, … D. Höglinger·bioRxiv·Nov 10, 2021
- Hyperspectral Counting of Multiplexed Nanoparticle Emitters in Single Cells and Organelles
P. V. Jena, M. A. Gravely, … D. A. Heller·bioRxiv·Nov 24, 2021
- Smart Slides for Optical Monitoring of Cellular Processes
J. Ackermann, E. Reger, … S. Kruss·bioRxiv·Aug 3, 2023